Publications by authors named "Katherine Kay"

Claim this Profile
I
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.
Katherine Kay, Justin Goodwin, Hanna Ehrlich, Joyce Ou, Tracey Freeman

Clin Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should Deep-Sequenced Amplicons Become the New Gold Standard for Analyzing Malaria Drug Clinical Trials?
Sam Jones, Katherine Kay, Eva Maria Hodel, Maria Gruenberg, Anita Lerch

Antimicrob Agents Chemother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating genetic selection into individual-based models of malaria and other infectious diseases.
Ian M Hastings, Diggory Hardy, Katherine Kay, Raman Sharma

Evol Appl· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy.
Sam Jones, Mateusz Plucinski, Katherine Kay, Eva Maria Hodel, Ian M Hastings

Antimicrob Agents Chemother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling HIV Pre-Exposure Prophylaxis.
Thomas Straubinger, Katherine Kay, Robert Bies

Front Pharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance.
Sam Jones, Eva Maria Hodel, Raman Sharma, Katherine Kay, Ian M Hastings

J Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach.
Katherine Kay, Keith Dolcy, Robert Bies, Dhaval K Shah

AAPS J· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically-based pharmacokinetic model of vaginally administered dapivirine ring and film formulations.
Katherine Kay, Dhaval K Shah, Lisa Rohan, Robert Bies

Br J Clin Pharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the impact of insecticide-based control interventions on the evolution of insecticide resistance and disease transmission.
Susana Barbosa, Katherine Kay, Nakul Chitnis, Ian M Hastings

Parasit Vectors· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Importance of Scientific Debate in the Identification, Containment, and Control of Artemisinin Resistance.
Ian M Hastings, Katherine Kay, Eva Maria Hodel

Clin Infect Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the pharmacology of antimalarial drug combination therapy.
Ian M Hastings, Eva Maria Hodel, Katherine Kay

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens.
Ghaith Aljayyoussi, Katherine Kay, Stephen A Ward, Giancarlo A Biagini

Malar J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment.
Eva Maria Hodel, Katherine Kay, Ian M Hastings

Antimicrob Agents Chemother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task".
Ian M Hastings, Katherine Kay, Eva Maria Hodel

Antimicrob Agents Chemother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Ian M Hastings, Katherine Kay, Eva Maria Hodel

Antimicrob Agents Chemother· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.
Katherine Kay, Eva Maria Hodel, Ian M Hastings

Antimicrob Agents Chemother· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-shifting in malaria incidence as a result of induced immunological deficit: a simulation study.
Peter Pemberton-Ross, Thomas A Smith, Eva Maria Hodel, Katherine Kay, Melissa A Penny

Malar J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring windows of selection for anti-malarial drug treatments.
Katherine Kay, Ian M Hastings

Malar J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials.
Katherine Kay, Eva Maria Hodel, Ian M Hastings

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.
Eva Maria Hodel, Katherine Kay, Daniel J Hayes, Dianne J Terlouw, Ian M Hastings

Malar J· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugs.
Katherine Kay, Ian M Hastings

PLoS Comput Biol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis